P
WVE icon

Pfizer’s Wave Life Sciences WVE Stock Holding History

Pfizer’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.9M Hold
1,875,000
– – 6.42% 5
2026
Q1 		$11.9M Hold
1,875,000
– – 5% 6
2025
Q4 		$31.9M Hold
1,875,000
– – 13.48% 4
2025
Q3 		$13.7M Hold
1,875,000
– – 3.14% 8
2025
Q2 		$12.2M Hold
1,875,000
– – 2.12% 6
2025
Q1 		$15.2M Hold
1,875,000
– – 3.02% 6
2024
Q4 		$23.2M Buy
+1,875,000
New +$25M 0.89% 7

Other funds holding WVE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
AG
Algert Global San Francisco, California $8.43B AUM 80.94% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Pfizer's WVE Position: Q2 2026 in Review

Pfizer held its Wave Life Sciences (WVE) position steady in Q2 2026 at 1,875,000 shares worth $10.9M. The position accounts for 6.42% of the portfolio, ranked #5.

Pfizer first reported a position in WVE in Q4 2024 and has held it in 7 quarters since. The position peaked at $31.9M in Q4 2025. 188 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Pfizer held 1,875,000 shares of Wave Life Sciences worth $10.9M as of Q2 2026.
  • Pfizer left its Wave Life Sciences share count unchanged in Q2 2026.
  • Wave Life Sciences made up 6.42% of Pfizer's portfolio in Q2 2026, its #5 holding.
  • Pfizer first reported a position in Wave Life Sciences in Q4 2024 and has held it in 7 quarters since.
  • Pfizer's Wave Life Sciences position peaked at $31.9M in Q4 2025.
  • 188 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Pfizer's 13F filing for Q2 2026, filed 13 Aug 2026.